Variant report

Variant	esv3374760
Chromosome Location	chr10:23480971-23483819
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:45)
CpG islands
(count:489)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:45 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr10:23481438-23481598	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTBP2	chr10:23479936-23482481	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr10:23481640-23481790	WERI-Rb-1	eye:	n/a	n/a
4	CTCF	chr10:23481705-23481880	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr10:23481823-23481847	Fibrobl	skin:	n/a	n/a
6	CTCF	chr10:23481680-23481830	HEK293	kidney:	n/a	n/a
7	CTCF	chr10:23481623-23481901	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTCF	chr10:23481750-23481858	Pancreas_OC	pancreas:	n/a	n/a
9	CTCF	chr10:23481540-23481870	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr10:23481859-23481893	Fibrobl	skin:	n/a	n/a
11	CTCF	chr10:23481680-23481830	WERI-Rb-1	eye:	n/a	n/a
12	E2F6	chr10:23480742-23481213	H1-hESC	embryonic stem cell:	n/a	chr10:23481163-23481172
13	E2F6	chr10:23481438-23482266	H1-hESC	embryonic stem cell:	n/a	n/a
14	E2F6	chr10:23480648-23481045	H1-hESC	embryonic stem cell:	n/a	n/a
15	E2F6	chr10:23481362-23482238	H1-hESC	embryonic stem cell:	n/a	n/a
16	EGR1	chr10:23481544-23481932	H1-hESC	embryonic stem cell:	n/a	n/a
17	GABPA	chr10:23480827-23481049	H1-hESC	embryonic stem cell:	n/a	chr10:23480925-23480934
18	GABPA	chr10:23481719-23482142	H1-hESC	embryonic stem cell:	n/a	n/a
19	HMGN3	chr10:23481340-23481424	K562	blood:	n/a	n/a
20	MAFK	chr10:23483713-23483794	HepG2	liver:	n/a	n/a
21	MAX	chr10:23480702-23481272	H1-hESC	embryonic stem cell:	n/a	n/a
22	MAX	chr10:23481338-23482300	H1-hESC	embryonic stem cell:	n/a	chr10:23481373-23481383
23	MAX	chr10:23481339-23482282	H1-hESC	embryonic stem cell:	n/a	chr10:23481373-23481383
24	MAX	chr10:23481800-23482091	H1-hESC	embryonic stem cell:	n/a	n/a
25	MAX	chr10:23481762-23482074	ECC-1	luminal epithelium:	n/a	n/a
26	NANOG	chr10:23481452-23481729	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr10:23481693-23482311	H1-neurons	neurons:	n/a	n/a
28	POLR2A	chr10:23481766-23482197	H1-neurons	neurons:	n/a	n/a
29	POLR2A	chr10:23483278-23485107	H1-neurons	neurons:	n/a	n/a
30	POLR2A	chr10:23483291-23484286	H1-neurons	neurons:	n/a	n/a
31	POLR2A	chr10:23482201-23482974	H1-neurons	neurons:	n/a	n/a
32	POLR2A	chr10:23482347-23482937	H1-neurons	neurons:	n/a	n/a
33	RAD21	chr10:23481633-23481844	H1-hESC	embryonic stem cell:	n/a	n/a
34	RAD21	chr10:23481631-23481911	H1-hESC	embryonic stem cell:	n/a	n/a
35	RAD21	chr10:23481500-23482019	H1-hESC	embryonic stem cell:	n/a	n/a
36	SIN3A	chr10:23481860-23481865	H1-hESC	embryonic stem cell:	n/a	n/a
37	SIN3A	chr10:23481237-23481395	H1-hESC	embryonic stem cell:	n/a	n/a
38	SUZ12	chr10:23483329-23485664	H1-hESC	embryonic stem cell:	n/a	n/a
39	SUZ12	chr10:23479777-23482696	H1-hESC	embryonic stem cell:	n/a	n/a
40	SUZ12	chr10:23479864-23482543	NT2-D1	testis:	n/a	n/a
41	TBP	chr10:23481678-23481963	H1-hESC	embryonic stem cell:	n/a	n/a
42	TBP	chr10:23482226-23482341	H1-hESC	embryonic stem cell:	n/a	n/a
43	ZNF143	chr10:23481289-23481641	H1-hESC	embryonic stem cell:	n/a	n/a
44	ZNF143	chr10:23483362-23483722	H1-hESC	embryonic stem cell:	n/a	chr10:23483546-23483561 chr10:23483545-23483564
45	ZNF263	chr10:23481214-23482132	HEK293-T-REx	kidney:	n/a	n/a

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:23481776-23481826	AoSMC	blood vessel:	n/a
2	chr10:23481776-23481826	AoSMC	blood vessel:	n/a
3	chr10:23481786-23481836	SKMC	muscle:	n/a
4	chr10:23481776-23481826	HCPEpiC	choroid plexus:	n/a
5	chr10:23481389-23481439	SK-N-SH_RA	brain:	n/a
6	chr10:23481421-23481471	BJ	skin:	n/a
7	chr10:23481385-23481435	HEEpiC	esophagus:	n/a
8	chr10:23481176-23481226	BE2_C	brain:	n/a
9	chr10:23481776-23481826	HCF	heart:	n/a
10	chr10:23481594-23481644	BE2_C	brain:	n/a
11	chr10:23481776-23481826	HUVEC	blood vessel:	n/a
12	chr10:23482255-23482305	BE2_C	brain:	n/a
13	chr10:23481786-23481836	GM12878	blood:	n/a
14	chr10:23481389-23481439	AG09309	skin:	n/a
15	chr10:23481389-23481439	GM12878	blood:	n/a
16	chr10:23481385-23481435	HCPEpiC	choroid plexus:	n/a
17	chr10:23481385-23481435	GM12878	blood:	n/a
18	chr10:23481421-23481471	Hela-S3	cervix:	n/a
19	chr10:23481176-23481226	IMR90	lung:	fetal
20	chr10:23481786-23481836	K562	blood:	n/a
21	chr10:23481594-23481644	AoSMC	blood vessel:	n/a
22	chr10:23481421-23481471	PFSK-1	brain:	n/a
23	chr10:23481786-23481836	NH-A	brain:	n/a
24	chr10:23481176-23481226	HCF	heart:	n/a
25	chr10:23481776-23481826	MCF10A-Er-Src	breast:	n/a
26	chr10:23481389-23481439	HRPEpiC	eye:	n/a
27	chr10:23481176-23481226	HepG2	liver:	n/a
28	chr10:23481776-23481826	HRCEpiC	kidney:	n/a
29	chr10:23481176-23481226	U87	brain:	n/a
30	chr10:23481594-23481644	HCF	heart:	n/a
31	chr10:23482255-23482305	HL-60	blood:	n/a
32	chr10:23481176-23481226	RPTEC	kidney:	n/a
33	chr10:23481786-23481836	U87	brain:	n/a
34	chr10:23481389-23481439	NH-A	brain:	n/a
35	chr10:23481385-23481435	SAEC	small airway:	n/a
36	chr10:23481385-23481435	HL-60	blood:	n/a
37	chr10:23482255-23482305	A549	lung:	n/a
38	chr10:23481385-23481435	PrEC	prostate:	n/a
39	chr10:23481786-23481836	SK-N-SH	brain:	n/a
40	chr10:23481389-23481439	MCF10A-Er-Src	breast:	n/a
41	chr10:23481385-23481435	RPTEC	kidney:	n/a
42	chr10:23481176-23481226	AG10803	skin:	n/a
43	chr10:23481776-23481826	HMEC	breast:	n/a
44	chr10:23481176-23481226	PFSK-1	brain:	n/a
45	chr10:23481385-23481435	ovcar-3	ovarian:	n/a
46	chr10:23481776-23481826	GM19239	blood:	n/a
47	chr10:23481421-23481471	GM12891	blood:	n/a
48	chr10:23482255-23482305	HEK293	kidney:	embryo
49	chr10:23481594-23481644	NT2-D1	testis:	n/a
50	chr10:23481389-23481439	HUVEC	blood vessel:	n/a

No data

Variant related genes	Relation type
PTF1A	TF binding region
PTF1A	CpG island

Extended variants
information (count: 128 )
Associated
traits (count: 37 )

Variant overlapped rSNPs/rCNVs (count:128 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs577025631	chr10:23481012-23481013	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs185209033	chr10:23481043-23481044	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs555790897	chr10:23481075-23481076	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs575613349	chr10:23481095-23481096	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs541560232	chr10:23481113-23481114	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs145216233	chr10:23481121-23481122	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs572623181	chr10:23481139-23481140	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs541220119	chr10:23481140-23481141	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs564810256	chr10:23481145-23481146	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs112034203	chr10:23481148-23481149	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs533495117	chr10:23481153-23481154	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs550492547	chr10:23481169-23481170	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs563700905	chr10:23481181-23481182	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs529287944	chr10:23481192-23481193	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs114630888	chr10:23481217-23481218	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs566009852	chr10:23481248-23481249	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs533992460	chr10:23481263-23481264	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs547318221	chr10:23481272-23481273	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs570624412	chr10:23481295-23481296	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs377316075	chr10:23481327-23481328	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs556026337	chr10:23481337-23481338	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs575648203	chr10:23481345-23481346	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs535055490	chr10:23481380-23481381	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs555444660	chr10:23481384-23481385	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs572003380	chr10:23481386-23481387	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs541109338	chr10:23481388-23481389	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs368811054	chr10:23481423-23481424	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs371934937	chr10:23481424-23481425	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs199869734	chr10:23481436-23481437	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs201994193	chr10:23481437-23481438	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs200997535	chr10:23481454-23481455	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs146089816	chr10:23481467-23481468	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs200273790	chr10:23481481-23481482	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs140097468	chr10:23481503-23481504	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs376887768	chr10:23481534-23481535	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs371045580	chr10:23481544-23481545	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs199831799	chr10:23481561-23481562	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs141937982	chr10:23481585-23481586	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs201397561	chr10:23481592-23481593	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs144291757	chr10:23481601-23481602	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs144692521	chr10:23481602-23481603	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs117678424	chr10:23481621-23481622	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs79353984	chr10:23481623-23481624	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs199556852	chr10:23481624-23481625	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs377294323	chr10:23481634-23481635	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs142955321	chr10:23481645-23481646	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs375826548	chr10:23481649-23481650	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs370434971	chr10:23481657-23481658	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs539214102	chr10:23481660-23481661	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs549685905	chr10:23481688-23481689	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:37)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Glioblastoma multiforme	22286061	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD

Chromatin state (count:190 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:23479200-23481600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
2	chr10:23479200-23483400	Active TSS	Pancreas	Pancrea
3	chr10:23479600-23481400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr10:23479800-23482600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
5	chr10:23480000-23481000	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr10:23480000-23481600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
7	chr10:23480000-23481800	Bivalent Enhancer	Fetal Brain Male	brain
8	chr10:23480200-23481200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr10:23480200-23482400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
10	chr10:23480200-23482600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
11	chr10:23480200-23484400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
12	chr10:23480400-23481000	Bivalent Enhancer	Right Ventricle	heart
13	chr10:23480400-23481400	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
14	chr10:23480400-23481400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
15	chr10:23480400-23481800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
16	chr10:23480400-23482400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
17	chr10:23480400-23482400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
18	chr10:23480400-23482600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr10:23480600-23481000	Bivalent Enhancer	Liver	Liver
20	chr10:23480600-23481600	Bivalent Enhancer	Colonic Mucosa	Colon
21	chr10:23480600-23481800	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
22	chr10:23480600-23482200	Bivalent Enhancer	Spleen	Spleen
23	chr10:23480800-23481000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
24	chr10:23480800-23481000	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr10:23480800-23481000	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
26	chr10:23480800-23481000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
27	chr10:23480800-23481000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr10:23480800-23481200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
29	chr10:23480800-23481200	Bivalent Enhancer	Brain Hippocampus Middle	brain
30	chr10:23480800-23481600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
31	chr10:23480800-23481600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
32	chr10:23480800-23481600	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
33	chr10:23480800-23481600	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr10:23480800-23481600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
35	chr10:23480800-23482000	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
36	chr10:23480800-23482200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
37	chr10:23480800-23482200	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
38	chr10:23480800-23482200	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
39	chr10:23480800-23482200	Bivalent/Poised TSS	Fetal Brain Female	brain
40	chr10:23480800-23482200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
41	chr10:23480800-23482800	Active TSS	Pancreatic Islets	Pancreatic Islet
42	chr10:23481000-23481200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr10:23481000-23481200	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr10:23481000-23481200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
45	chr10:23481000-23481200	Active TSS	Primary hematopoietic stem cells	blood
46	chr10:23481000-23481200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr10:23481000-23481600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
48	chr10:23481000-23481600	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
49	chr10:23481000-23481600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr10:23481000-23482200	Flanking Bivalent TSS/Enh	Right Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links